glp-1 rfk Jr. considering 'framework' for Medicaid, Medicare coverage of GLP-1s America's Obesity Epidemic Is Finally
Description
Inject slowly and the thin needle becomes a genuine comfort advantage
JCL roundtable
Marx W, McGuinness AJ, Rocks T, Ruusunen A, Cleminson J, Walker AJ, et al
While there is no compelling evidence to demonstrate that GLP-1s medications lead to excess muscle loss, numerous pharmaceutical companies are still looking for ways to combine GLP-1 medications with other compounds to better maintain muscle mass
Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides
doi: 10.1002/hep.31856
